The global coronary artery bypass graft (CABG) market was valued at US$ 10.2 Bn in 2022 and is estimated to grow at a CAGR of 5.1% from 2023 to 2031, reaching US$ 15.8 Bn by the end of 2031. The market is witnessing substantial growth due to the increasing prevalence of cardiovascular diseases, rising geriatric population, and growing demand for advanced cardiac surgical procedures. Coronary artery bypass grafting remains one of the most effective treatments for severe coronary artery disease, helping improve blood flow to the heart and reducing the risk of heart attacks. Technological advancements in minimally invasive surgeries and robotic-assisted procedures are further transforming the global CABG market landscape.

Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20828

Market Overview

The coronary artery bypass graft market plays a critical role in the global cardiovascular healthcare industry, as heart disease continues to remain one of the leading causes of mortality worldwide. CABG procedures are widely performed to treat blocked coronary arteries by redirecting blood flow through grafted blood vessels, thereby restoring oxygen supply to the heart muscle. Rising awareness regarding early diagnosis and treatment of cardiovascular disorders, coupled with improved healthcare infrastructure, is fueling the demand for CABG procedures globally. Furthermore, innovations in surgical instruments, imaging systems, and grafting technologies are enabling surgeons to perform safer and more efficient procedures, improving patient outcomes and recovery times.

Market Size and Growth

Valued at US$ 10.2 Bn in 2022, the coronary artery bypass graft market is projected to reach US$ 15.8 Bn by 2031, expanding at a CAGR of 5.1% during the forecast period. The market’s steady growth is driven by increasing incidences of obesity, hypertension, diabetes, and unhealthy lifestyles, all of which significantly contribute to coronary artery disease. Additionally, the growing aging population across developed and developing countries is increasing the number of patients requiring bypass surgeries. Governments and healthcare organizations are also investing heavily in cardiac care infrastructure, further supporting market growth. Advancements in minimally invasive CABG procedures are expected to increase patient preference for surgical interventions, thereby boosting market demand.

Market Segmentation

The coronary artery bypass graft market can be segmented based on procedure type, device type, and end-user. By procedure type, the market includes on-pump CABG and off-pump CABG, with off-pump procedures gaining popularity due to reduced complications and faster recovery. In terms of device type, the market comprises heart-lung machines, stabilizers, grafting devices, and surgical instruments. End-users include hospitals, specialty cardiac centers, and ambulatory surgical centers, with hospitals accounting for the largest market share due to the high volume of complex cardiac procedures performed in these facilities. Increasing adoption of technologically advanced surgical tools and robotic systems is further shaping the segmentation landscape.

Regional Analysis

Regionally, North America dominates the global coronary artery bypass graft market, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and significant healthcare expenditure. Europe also holds a substantial share, supported by increasing awareness of heart health and strong adoption of advanced surgical technologies. Asia-Pacific is expected to witness the fastest growth during the forecast period due to rising healthcare investments, expanding medical tourism, and increasing incidences of cardiac disorders in countries such as China and India. Meanwhile, Latin America and the Middle East & Africa are emerging markets, offering considerable opportunities as access to cardiac care services continues to improve.

Competitive Landscape

The global CABG market is highly competitive, with leading players focusing on product innovation, strategic partnerships, and mergers and acquisitions to strengthen their market positions. Prominent companies operating in the global landscape include Boston Scientific, Medtronic Plc, TERUMO CORPORATION, KARL STORZ GmbH & Co. KG, Sorin Group (LivaNova PLC), Ethicon US, LLC (Johnson & Johnson), NeoGraft Technologies, Inc., Edwards Lifesciences Corporation, MAQUET Holding B.V. & Co. KG, and Genesee Biomedical Inc. These companies are investing heavily in research and development to introduce advanced surgical solutions and improve procedural efficiency. The focus on minimally invasive technologies and enhanced patient safety continues to drive innovation across the market.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453